Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Incidence and Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Agents

Miriam Kimpton, MD, Ryan Buyting, Daniel J Corsi, PhD, Natasha Rupani, MD, Marc Carrier, MD, MSc, Arleigh McCurdy, MD

Blood (2016) 128 (22): 2624.

https://doi.org/10.1182/blood.V128.22.2624.2624

Published: 2016

Journal Articles

Risk of Venous Thromboembolism in Hospitalized Patients with Sickle Cell Disease

Joshua Taylor, Alexandra Anghel, Daniel J Corsi, PhD, Marc Carrier, MD, MSc, Alan Tinmouth, MD FRCPC, Elianna Saidenberg, MD

Blood (2016) 128 (22): 4755.

https://doi.org/10.1182/blood.V128.22.4755.4755

Published: 2016

Journal Articles

Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease?

Philip S Wells, MD, Michael J. Kovacs, MD FRCPC, David Anderson, MD, Susan R. Kahn, MD, Clive Kearon, MB, Sam Schulman, MD PhD FRCPC, David M. Keeling, MD, Scott Kaatz, DO, MSc, Susan Solymoss, MD, Daniel J Corsi, PhD, Marc Rodger, MD MSc, FRCPC

Blood (2016) 128 (22): 272.

https://doi.org/10.1182/blood.V128.22.272.272

Published: 2016

Journal Articles

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism

Ryma Ihaddadene, Daniel J. Corsi, Alejandro Lazo-Langner, Sudeep Shivakumar, Ryan Zarychanski, Vicky Tagalakis, Susan Solymoss, Nathalie Routhier, James Douketis, Gregoire Le Gal, Marc Carrier

Blood (2016) 127 (16): 2035–2037.

https://doi.org/10.1182/blood-2015-11-682963

Published: 2016

Journal Articles

Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism

Ryma Ihaddadene, BHSc, MSc, Daniel J Corsi, PhD, Alejandro Lazo-Langner, MD, Sudeep Shivakumar, MD, Vicky Tagalakis, MD MSc, Ryan Zarychanski, MD MSc, Susan Solymoss, MD, Nathalie Routhier, MD, James D. Douketis, MD, Marc Carrier, MD MSc

Blood (2015) 126 (23): 625.

https://doi.org/10.1182/blood.V126.23.625.625

Published: 2015

NARROW

Incidence and Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Agents

Risk of Venous Thromboembolism in Hospitalized Patients with Sickle Cell Disease

Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease?

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism

Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism

Email alerts

ASH Publications

American Society of Hematology

Incidence and Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Agents

Risk of Venous Thromboembolism in Hospitalized Patients with Sickle Cell Disease

Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease?

Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism

Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only